Mito Immune Therapeutics is a drug research and development biotech company.
Mitoimmune Therapeutics has raised $3.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Mitoimmune Therapeutics's investors include Quantum Ventures Korea, IMM Investment, SL Investment, Korea Development Bank, KB Investment.
Mitoimmune Therapeutics is headquartered in Seoul, South Korea.
Mito Immune Therapeutics is a drug research and development biotech company.
Mitoimmune Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mitoimmune Therapeutics — Funding & Investors." VCBacked, September 21, 2023, https://www.vcbacked.co/company/mitoimmune-therapeutics. Accessed August 3, 2026.
VCBacked. (2023). Mitoimmune Therapeutics — Funding & Investors. Retrieved August 3, 2026, from https://www.vcbacked.co/company/mitoimmune-therapeutics
{{cite web |title=Mitoimmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mitoimmune-therapeutics |website=VCBacked |access-date=August 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated